Open access

The spectrum of multisystem inflammatory syndrome (MIS-C) in children infected with severe acute respiratory syndrome coronavirus 2

Publication: LymphoSign Journal
11 May 2021

Abstract

Introduction: The impact of SARS-CoV-2 infections in children has generally been described as relatively benign. However, since April 2020, there have been reports of a new multisystem inflammatory illness affecting children and related to COVID-19 termed multisystem inflammatory syndrome in children (MIS-C).
Aim: To describe 3 cases of children diagnosed with MIS-C and discuss the disease spectrum.
Methods: We collected and reviewed data from 3 cases diagnosed with MIS-C admitted to our pediatric ward between October 2020 and January 2021.
Discussion: MIS-C is a newly described disease that spans a spectrum of phenotypes and severity, and while it shares clinical similarities with Kawasaki disease, it has a unique set of epidemiological, laboratory, and prognostic characteristics. In this review, we hope to add to the understanding of this new entity.
Statement of Novelty: This report discusses 3 cases of MIS-C and elaborates on the spectrum and immunology of this entity. Our cases are unique in their relatively wide spectrum and variability. We hope our own experience with MIS-C adds to the accumulating knowledge and understanding of this emerging disease.

Formats available

You can view the full content in the following formats:

REFERENCES

Abrams J.Y., Godfred-Cato S.E., Oster M.E., Chow E.J., Koumans E.H., Bryant B., Leung J.W., and Belay E.D. 2020. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. The Journal of Pediatrics, 226: 45–54.e1.
Ahmed M., Advani S., Moreira A., Zoretic S., Martinez J., Chorath K., Acosta S., Naqvi R., Burmeister-Morton F., Burmeister F., Tarriela A., Petershack M., Evans M., Hoang A., Rajasekaran K., Ahuja S., and Moreira A. 2020. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine, 26: 100527. [online]. Available from https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30271-6/fulltext [accessed 25 September 2020].
Alsaied T., Tremoulet A.H., Burns J.C., Saidi A., Dionne A., Lang S.M., Newburger J.W., de Ferranti S., and Friedman K.G. 2021. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation, 143(1): 78–88. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/33166178/ [accessed 21 April 2021].
Arad G., Levy R., Nasie I., Hillman D., Rotfogel Z., Barash U., Supper E., Shpilka T., Minis A., and Kaempfer R. 2011. Binding of superantigen toxins into the cd28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biol. 9(9): e1001149. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/21931534/ [accessed 21 April 2021].
Bautista-Rodriguez C., Sanchez-de-Toledo J., Clark B.C., Herberg J., Bajolle F., Randanne P.C., Salas-Mera D., Foldvari S., Chowdhury D., Munoz R., Bianco F., Singh Y., Levin M., Bonnet D., and Fraisse A. 2021. Multisystem Inflammatory syndrome in children: An international survey. Pediatrics, 147(2): e2020024554. Available from https://pubmed.ncbi.nlm.nih.gov/33234669/.
Bertoncelli D., Guidarini M., Della Greca A., Ratti C., Falcinella F., Iovane B., Dutto M.L., Caffarelli C., and Tchana B. 2020. COVID19: Potential cardiovascular issues in pediatric patients. Acta Bio-Medica: Atenei Parmensis, 91(2): 177–183. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/32420942/ [accessed 21 April 2021].
Bustos B.R., Jaramillo-Bustamante J.C., Vasquez-Hoyos P., Cruces P., and Díaz F. 2021. Pediatric inflammatory multisystem syndrome associated with sars-cov-2: a case series quantitative systematic review. Pediatr. Emerg. Care, 37(1): 44–47.
Castagnoli R., Votto M., Licari A., Brambilla I., Bruno R., Perlini S., Rovida F., Baldanti F., and Marseglia G.L. 2020. Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection in children and adolescents: a systematic review. JAMA pediatrics, 174(9): 882–889.
Centers for Disease Control and Prevention. 2021. Multisystem inflammatory syndrome in children (MIS-C) [online]. Available from https://www.cdc.gov/mis-c/hcp/ [accessed 28 February 2021].
Chen M.-R., Kuo H.-C., Lee Y.-J., Chi H., Li S.C., Lee H.-C., and Yang K.D. 2021. Phenotype, susceptibility, autoimmunity, and immunotherapy between kawasaki disease and coronavirus disease-19 associated multisystem inflammatory syndrome in children. Frontiers in Immunol. 12: 632890. [online]. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959769/ [accessed 21 April 2021].
Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L., Willscher E., Binder M., Arditi M., and Bahar I. 2020. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. USA. 117(41): 25254–25262.
Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., Santilli V., Campbell T., Bryceson Y., Eriksson D., Wang J., Marchesi A., Lakshmikanth T., Campana A., Villani A., and Rossi P. 2020. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell, 183(4): 968–981.e7. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/32966765/ [accessed 21 April 2021].
Datadashboard.health.gov.il. n.d. קורונה – לוח בקרה [online]. Available from https://datadashboard.health.gov.il/COVID-19/general.
Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., Udo T., Kumar J., Pulver W., Smith L., Hutton B., Blog D., and Zucker H. 2020. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 383(4): 347–358.
Eleftheriou D., Levin M., Shingadia D., Tulloh R., Klein N., and Brogan P. 2013. Management of Kawasaki disease. Arch. Dis. Child. 99(1): 74–83. [online]. Available from https://adc.bmj.com/content/99/1/74#T2.
European Centre for Disease Prevention and Control. 2020 Rapid risk assessment: paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children [online]. Available from https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-paediatric-inflammatory-multisystem-syndrome-15-May-2020.pdf. Updated 2020. [accessed 1 March 2021].
Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., Singh A.R., Li S., Tarquinio K.M., Jaggi P., Oster M.E., Zackai S.P., Gillen J., Ratner A.J., Walsh R.F., and Fitzgerald J.C. 2020. Multisystem inflammatory syndrome in US. children and adolescents. N. Engl. J. Med. 383(4): 334–346.
Junior H.S., Sakano T.M.S., Rodrigues R.M., Eisencraft A.P., Carvalho V.E.L.de, Schvartsman C., and da Costa Reis A.G.A. 2020. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician’s point of view. J Pediatr (Rio J), 97(2): 140–159.
Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., and Villapol S. 2021. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/33532785/ [accessed 2 March 2021].
Ludvigsson J.F. 2021. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 110(3): 914–921.
Ng K.F., Kothari T., Bandi S., Bird P.W., Goyal K., Zoha M., Rai V., and Tang J.W. 2020. COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J. Med. Virol. 92(11): 2880–2886.
Noval Rivas M., Porritt R.A., Cheng M.H., Bahar I., and Arditi M. 2020. COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis. J Allergy Clin Immunol. 147(1): 57–59.
Ramcharan T., Nolan O., Lai C.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., Al-Abadi E., Scholefield B.R., and Chikermane A. 2020. Paediatric Inflammatory Multisystem Syndrome: Temporally associated with SARS-CoV-2 (PIMS-TS): Cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr. Cardiol. 41(7): 1391–1401. [online]. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289638/#CR20 [accessed 15 November 2020].
RCPCH. n.d. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) – guidance for clinicians [online]. Available from https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance.
Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., and Theocharis P. 2020. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 395(10237): 1607–1608. [online]. Available from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31094-1/fulltext [accessed 13 May 2020].
Taquet M., Luciano S., Geddes J.R., and Harrison P.J. 2020. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry, 8(2): 130–140.
Toubiana J., Poirault C., Corsia A., Bajolle F., Fourgeaud J., Angoulvant F., Debray A., Basmaci R., Salvador E., Biscardi S., Frange P., Chalumeau M., Casanova J.-L., Cohen J.F., and Allali S. 2020. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ, 369: m2094.
Valverde I., Singh Y., Sanchez-de-Toledo J., Theocharis P., Chikermane A., Di Filippo S., Kuciñska B., Mannarino S., Tamariz-Martel A., Gutierrez-Larraya F., Soda G., Vandekerckhove K., Gonzalez-Barlatay F., McMahon C.J., Marcora S., Napoleone C.P., Duong P., Tuo G., Deri A., and Nepali G. 2021. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation, 143(1): 21–32. [online]. Available from https://pubmed.ncbi.nlm.nih.gov/33166189/ [accessed 21 April 2021].
Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., and D’Antiga L. 2020. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 395(10239): 1771–1778. [online]. Available from https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931103-X [accessed 15 May 2020].
Viner R.M. and Whittaker E. 2020. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 395(10239): 1741–1743.
Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., Kucera F., Brierley J., McDougall M., Carter M., Tremoulet A., Shimizu C., Herberg J., Burns J.C., Lyall H., and Levin M. 2020. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated With SARS-CoV-2. JAMA, 324(3): 259–269. [online]. Available from https://jamanetwork.com/journals/jama/fullarticle/2767209 [accessed 19 June 2020].
World Health Organisation. 2021. WHO COVID-19 dashboard. covid19.who.int. [online]. Available from https://covid19.who.int/.
www.who.int. n.d. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 [online]. Available from https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., and Dong W. 2021. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 27(1): 89–95. [online]. Available from https://www.sciencedirect.com/science/article/abs/pii/S1198743X20305759 [accessed 15 January 2021].

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 8Number 2June 2021
Pages: 48 - 54

History

Received: 27 March 2021
Accepted: 3 May 2021
Accepted manuscript online: 11 May 2021

Authors

Affiliations

Edith Wolfson Medical center, Holon, IL
Adi Ovadia
Edith Wolfson Medical center, Holon, IL
Gila Meirson
Edith Wolfson Medical center, Holon, IL
Diana Tasher
Edith Wolfson Medical center, Holon, IL
Tel-Aviv University, Sackler Faculty of Medicine, Tel Aviv, IL
Ilan Dalal
Edith Wolfson Medical center, Holon, IL
Tel-Aviv University, Sackler Faculty of Medicine, Tel Aviv, IL

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media